These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 17240036

  • 1. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
    Patard JJ, Pantuck AJ, Crepel M, Lam JS, Bellec L, Albouy B, Lopes D, Bernhard JC, Guillé F, Lacroix B, De La Taille A, Salomon L, Pfister C, Soulié M, Tostain J, Ferriere JM, Abbou CC, Colombel M, Belldegrun AS.
    Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
    [Abstract] [Full Text] [Related]

  • 2. [Do broader indications for partial nephrectomy result in excess morbidity?].
    Verhoest G, Crepel M, Bernhard JC, Bellec L, Albouy B, Lopes D, Lacroix B, De La Taille A, Salomon L, Pfister C, Soulié M, Tostain J, Ferrière JM, Abbou CC, Colombel M, Vincendeau S, Bensalah K, Manunta A, Guillé F, Patard JJ.
    Prog Urol; 2008 Apr; 18(4):207-13. PubMed ID: 18501300
    [Abstract] [Full Text] [Related]

  • 3. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S, Vander Eeckt K, Srirangam SJ, Van Poppel H.
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [Abstract] [Full Text] [Related]

  • 4. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M, Meixl H, Polajnar M, Rauchenwald M, Jeschke K, Madersbacher S.
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [Abstract] [Full Text] [Related]

  • 5. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M.
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [Abstract] [Full Text] [Related]

  • 6. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG.
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M, Hupertan V, Comperat E, Renard-Penna R, Vaessen C, Conort P, Bitker MO, Chartier-Kastler E, Richard F, Rouprêt M.
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [Abstract] [Full Text] [Related]

  • 8. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Piñeiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ.
    Eur Urol; 2010 Mar; 57(3):466-71. PubMed ID: 19359089
    [Abstract] [Full Text] [Related]

  • 9. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K, Pantuck AJ, Crepel M, Verhoest G, Méjean A, Valéri A, Ficarra V, Pfister C, Ferrière JM, Soulié M, Cindolo L, De La Taille A, Tostain J, Chautard D, Schips L, Zigeuner R, Abbou CC, Lobel B, Salomon L, Lechevallier E, Descotes JL, Guillé F, Colombel M, Belldegrun AS, Patard JJ.
    BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
    [Abstract] [Full Text] [Related]

  • 10. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm.
    Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stöckle M.
    Eur Urol; 2006 Jun; 49(6):1058-63; discussion 1063-4. PubMed ID: 16630686
    [Abstract] [Full Text] [Related]

  • 11. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
    Roos FC, Pahernik S, Brenner W, Thüroff JW.
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
    [Abstract] [Full Text] [Related]

  • 12. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [Abstract] [Full Text] [Related]

  • 13. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [Abstract] [Full Text] [Related]

  • 14. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N, Hakenberg OW, Novotny V, Manseck A, Oehlschläger S, Wirth MP.
    Scand J Urol Nephrol; 2007 Mar; 41(1):10-3. PubMed ID: 17366096
    [Abstract] [Full Text] [Related]

  • 15. [What is the clinical practice of partial nephrectomy in France?].
    Bernhard JC, Ferriere JM, Crepel M, Wallerand H, Bellec L, Lacroix B, Lopes D, Albouy B, Robert G, Ravaud A, Colombel M, Tostain J, Pfister C, Soulie M, Salomon L, De La Taille A, Pasticier G, Abbou CC, Manunta A, Guille F, Patard JJ.
    Prog Urol; 2008 Jul; 18(7):428-34. PubMed ID: 18602602
    [Abstract] [Full Text] [Related]

  • 16. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.
    Gratzke C, Seitz M, Bayrle F, Schlenker B, Bastian PJ, Haseke N, Bader M, Tilki D, Roosen A, Karl A, Reich O, Khoder WY, Wyler S, Stief CG, Staehler M, Bachmann A.
    BJU Int; 2009 Aug; 104(4):470-5. PubMed ID: 19239445
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, Claessens I, Sylvester R, European Organization for Research and Treatment of Cancer (EORTC), National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), Southwest Oncology Group (SWOG), Eastern Cooperative Oncology Group (ECOG).
    Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
    [Abstract] [Full Text] [Related]

  • 18. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH, Jain S, Benway BM, Figenshau RS.
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [Abstract] [Full Text] [Related]

  • 19. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S, Roos F, Röhrig B, Wiesner C, Thüroff JW.
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [Abstract] [Full Text] [Related]

  • 20. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up.
    Denzinger S, Ganzer R, Fink A, Wieland WF, Blana A.
    Scand J Urol Nephrol; 2007 Jan; 41(6):496-500. PubMed ID: 17853016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.